Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-05-04 @ 6:01 AM
Study NCT ID:
NCT01340651
Status:
COMPLETED
Last Update Posted:
2014-03-10
First Post:
2011-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients
Sponsor:
Incyte Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
18424-260
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None